The Role of PI3K Inhibitors in Relapsed/Refractory FL and MZL

Jason M. Melear, MD, and Ian W. Flinn, MD, PhD, discuss the role of PI3K inhibitors in the management of R/R follicular lymphoma and marginal zone lymphoma.